Machine learning-derived mast cell-associated angiogenesis features can serve as prognostic targets for clear cell renal cell carcinoma.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Methods and Results: single-cell/bulk transcriptomics; LASSO+CoxBoost MCAS built and evaluated across TCGA-KIRC, E-MTAB-1980, GSE167573; qRT-PCR gene expression corroboration. Prognostic associations remain observational.
Technology: LASSO and CoxBoost analyze transcriptomic features to derive mast-cell-associated angiogenesis prognostic scores.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- LASSO and CoxBoost analyze transcriptomic features to derive mast-cell-associated angiogenesis prognostic scores.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13458499/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.